Impact of Statin Therapy on Systemic Inflammation, Left Ventricular Systolic and Diastolic Function and Prognosis in Low Risk Ischemic Heart Disease Patients without History of Congestive Heart Failure-Reference-Cited by-同舟云学术

Impact of Statin Therapy on Systemic Inflammation, Left Ventricular Systolic and Diastolic Function and Prognosis in Low Risk Ischemic Heart Disease Patients without History of Congestive Heart Failure

Published:2007 Issue:17 Volume:46 Page:1337-1343
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Okura Hiroyuki¹,Asawa Koichiro¹,Kubo Tomoichiro¹,Taguchi Haruyuki¹,Toda Iku¹,Yoshiyama Minoru²,Yoshikawa Junichi³,Yoshida Kiyoshi⁴

Affiliation:

1. Division of Cardiology, Bell Land General Hospital

2. Division of Internal Medicine and Cardiology, Osaka City University Medical School

3. Division of Internal Medicine and Cardiology, Osaka Ekisaikai Hospital

4. Division of Cardiology, Kawasaki Medical School

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/46/17/46_17_1337/_pdf

Reference28 articles.

1. Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy

2. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure

3. Statin therapy is associated with lower mortality among patients with severe heart failure

4. Statin Therapy May Be Associated With Lower Mortality in Patients With Diastolic Heart Failure

5. Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Statins in Heart Failure with Preserved Ejection Fraction: Current Evidence and Perspectives;International Journal of Molecular Sciences;2024-05-01

2. Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF);International Journal of Cardiology;2023-02

3. Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction;Frontiers in Cardiovascular Medicine;2023-01-12

4. Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study;Journal of Clinical Medicine;2022-07-04

5. Simvastatin-Loaded Nanofibrous Membrane Efficiency on the Repair of Achilles Tendons;International Journal of Nanomedicine;2022-03